Safety & Efficacy of NAB001 in the Treatment of Mild to Moderate Onychomycosis of the Toenails

NCT01208168 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

468

Enrollment

INDUSTRY

Sponsor class

Conditions

Onychomycosis

Interventions

DRUG: NAB001
DRUG: Vehicle alone

Sponsor

Promius Pharma, LLC